In-silico Drug Design and in-silico screening

In-silico drug design can take part much in all stages of drug development from the preclinical discovery stage to late stage clinical development.

During the process of selection of novel drug candidates, many essential steps are taken to eliminate such compounds that have side effects and also show interaction with other drugs. In-silico drug designing softwares show an important role to design progressive proteins or drugs in biotechnology or the pharmaceutical field. 

  • Structural Biology
  • Molecular Docking
  • Virtual Screening Methods
  • Computation approaches for fragment based Drug Discovery
  • Intellectual property issues arising from in silico Discovery
  • Enzyme Inhibitors

Related Conference of In-silico Drug Design and in-silico screening

August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
August 29-30, 2018 |

International Conference and Exhibition on Drug Safety & Pharmacovigilance

Park Inn By Radisson, Toronto, Canada
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 14-15, 2018

13th International Conference on Biosimilars and Biologics

Lisbon, Portugal
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

In-silico Drug Design and in-silico screening Conference Speakers

Recommended Sessions

Related Journals

Are you interested in